PREVALENCE OF DIABETIC RETINOPATHY IN TYPE 2 DIABETES MELLITUS PATIENTS

Main Article Content

Dr. Manika Jain

Keywords

Diabetic retinopathy, Type 2 diabetes mellitus, Prevalence, Risk factors, Glycemic control

Abstract

 Diabetic retinopathy represents a leading cause of preventable blindness globally, with significant variations in prevalence across different populations. Understanding local disease burden is essential for developing targeted screening strategies and preventive interventions.


Methods: A total of 130 type 2 diabetes mellitus patients aged 30 years and above were recruited using convenience sampling. Comprehensive ophthalmological examinations including digital fundus photography and optical coherence tomography were performed following pupillary dilatation. Demographic data, clinical parameters, and laboratory investigations including HbA1c levels were collected. Statistical analysis employed chi-square tests, independent t-tests, and multivariate logistic regression using SPSS version 23.0.


Results: Diabetic retinopathy prevalence was 32.3% among study participants. Patients with retinopathy were significantly older (62.1±11.8 vs 56.8±12.6 years, p=0.024) with longer diabetes duration (12.4±7.1 vs 6.8±4.9 years, p<0.001) and higher HbA1c levels (10.2±2.3 vs 8.2±1.7%, p<0.001). Mild nonproliferative diabetic retinopathy was most common (42.9%), while sight-threatening retinopathy affected 23.8% of cases. Multivariate analysis identified diabetes duration (OR=1.12, p<0.001), poor glycemic control with HbA1c >9% (OR=4.28, p=0.001), nephropathy (OR=3.42, p=0.004), and hypertension (OR=2.38, p=0.024) as independent risk factors. Diabetic macular edema was present in 28.6% of retinopathy patients, with bilateral involvement in 66.7% of cases.


Conclusion: The substantial diabetic retinopathy burden emphasizes the critical importance of systematic screening programs, intensive glycemic control, and comprehensive cardiovascular risk management for preventing vision-threatening complications in diabetic patients.

Abstract 66 | Pdf Downloads 21

References

1. Brownlee, M. (2001). The pathobiology of diabetic complications: A unifying mechanism. Diabetes, 50(6), 1126-1133. https://doi.org/10.2337/diabetes.50.6.1126
2. Early Treatment Diabetic Retinopathy Study Research Group. (1991). Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. Ophthalmology, 98(5), 786-806. https://doi.org/10.1016/S0161-6420(13)38012-9
3. Klein, R., Klein, B. E., Moss, S. E., Davis, M. D., & DeMets, D. L. (1984). The Wisconsin epidemiologic study of diabetic retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Archives of Ophthalmology, 102(4), 520-526. https://doi.org/10.1001/archopht.1984.01040030398010
4. Narendran, V., John, R. K., Raghuram, A., Ravindran, R. D., Nirmalan, P. K., & Thulasiraj, R. D. (2002). Diabetic retinopathy among self reported diabetics in southern India: The Aravind Comprehensive Eye Survey. British Journal of Ophthalmology, 86(9), 1014-1018. https://doi.org/10.1136/bjo.86.9.1014
5. Raman, R., Rani, P. K., Reddi Rachepalle, S., Gnanamoorthy, P., Uthra, S., Kumaramanickavel, G., & Sharma, T. (2009). Prevalence of diabetic retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study report 2. Ophthalmology, 116(2), 311-318. https://doi.org/10.1016/j.ophtha.2008.09.010
6. UK Prospective Diabetes Study (UKPDS) Group. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet, 352(9131), 837-853. https://doi.org/10.1016/S0140-6736(98)07019-6
7. Yau, J. W., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., ... & Wong, T. Y. (2012). Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care, 35(3), 556-564. https://doi.org/10.2337/dc11-1909
8. Brownlee, M. (2001). The pathobiology of diabetic complications: A unifying mechanism. Diabetes, 50(6), 1126-1133. https://doi.org/10.2337/diabetes.50.6.1126
9. Early Treatment Diabetic Retinopathy Study Research Group. (1991). Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. Ophthalmology, 98(5), 786-806. https://doi.org/10.1016/S0161-6420(13)38012-9
10. Klein, R., Klein, B. E., Moss, S. E., Davis, M. D., & DeMets, D. L. (1984). The Wisconsin epidemiologic study of diabetic retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Archives of Ophthalmology, 102(4), 520-526. https://doi.org/10.1001/archopht.1984.01040030398010
11. Klein, R., Klein, B. E., Moss, S. E., & Cruickshanks, K. J. (1989). The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology, 105(10), 1801-1815. https://doi.org/10.1016/S0161-6420(98)91020-X
12. Narendran, V., John, R. K., Raghuram, A., Ravindran, R. D., Nirmalan, P. K., & Thulasiraj, R. D. (2002). Diabetic retinopathy among self reported diabetics in southern India: The Aravind Comprehensive Eye Survey. British Journal of Ophthalmology, 86(9), 1014-1018. https://doi.org/10.1136/bjo.86.9.1014
13. Nathan, D. M., Cleary, P. A., Backlund, J. Y., Genuth, S. M., Lachin, J. M., Orchard, T. J., ... & Zinman, B. (2005). Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. New England Journal of Medicine, 353(25), 2643-2653. https://doi.org/10.1056/NEJMoa052187
14. Pradhan, R., Dhakal, R., Poudyal, G., Shrestha, S., & Mathema, P. (2017). Prevalence of diabetic retinopathy in type 2 diabetes mellitus patients attending diabetes clinic at Kathmandu Medical College Teaching Hospital. Kathmandu University Medical Journal, 15(59), 195-199. https://doi.org/10.3126/kumj.v15i59.20833
15. Raman, R., Rani, P. K., Reddi Rachepalle, S., Gnanamoorthy, P., Uthra, S., Kumaramanickavel, G., & Sharma, T. (2009). Prevalence of diabetic retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study report 2. Ophthalmology, 116(2), 311-318. https://doi.org/10.1016/j.ophtha.2008.09.010
16. Schrier, R. W., Estacio, R. O., Esler, A., & Mehler, P. (2002). Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney International, 61(3), 1086-1097. https://doi.org/10.1046/j.1523-1755.2002.00213.x
17. Sivaprasad, S., Gupta, B., Crosby-Nwaobi, R., & Evans, J. (2012). Prevalence of diabetic retinopathy in various ethnic groups: A worldwide perspective. Survey of Ophthalmology, 57(4), 347-370. https://doi.org/10.1016/j.survophthal.2012.01.004
18. UK Prospective Diabetes Study (UKPDS) Group. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet, 352(9131), 837-853. https://doi.org/10.1016/S0140-6736(98)07019-6
19. Varma, R., Torres, M., Peña, F., Klein, R., & Azen, S. P. (2004). Prevalence of diabetic retinopathy in adult Latinos: The Los Angeles Latino eye study. Ophthalmology, 111(7), 1298-1306. https://doi.org/10.1016/j.ophtha.2004.03.002
20. Wong, T. Y., Klein, R., Islam, F. M. A., Cotch, M. F., Folsom, A. R., Klein, B. E., ... & Sharrett, A. R. (2006). Diabetic retinopathy in a multi-ethnic cohort in the United States. American Journal of Ophthalmology, 141(3), 446-455. https://doi.org/10.1016/j.ajo.2005.08.063
21. Yau, J. W., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., ... & Wong, T. Y. (2012). Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care, 35(3), 556-564. https://doi.org/10.2337/dc11-1909